Jounce Therapeutics, Inc is a biotechnology business based in the US. Jounce Therapeutics shares (JNCE) are listed on the NASDAQ and all prices are listed in US Dollars. Jounce Therapeutics employs 128 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Jounce Therapeutics
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – JNCE – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Jounce Therapeutics stock price (NASDAQ: JNCE)Use our graph to track the performance of JNCE stocks over time.
Jounce Therapeutics shares at a glance
|Latest market close||$7.85|
|52-week range||$4.43 - $14.84|
|50-day moving average||$7.02|
|200-day moving average||$9.29|
|Wall St. target price||$16.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.63|
Buy Jounce Therapeutics shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Jounce Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Jounce Therapeutics price performance over time
|1 week (2021-07-12)||N/A|
|1 month (2021-06-23)||5.09%|
|3 months (2021-04-19)||N/A|
|6 months (2021-01-19)||N/A|
|1 year (2020-07-19)||N/A|
|2 years (2019-07-19)||N/A|
|3 years (2018-07-19)||N/A|
|5 years (2016-07-19)||N/A|
Is Jounce Therapeutics under- or over-valued?
Valuing Jounce Therapeutics stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Jounce Therapeutics's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Jounce Therapeutics's EBITDA
Jounce Therapeutics's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $22.6 million.
The EBITDA is a measure of a Jounce Therapeutics's overall financial performance and is widely used to measure a its profitability.
Jounce Therapeutics financials
|Revenue TTM||$63.9 million|
|Gross profit TTM||$25.3 million|
|Return on assets TTM||-11.4%|
|Return on equity TTM||-20.34%|
|Market capitalisation||$282.7 million|
TTM: trailing 12 months
Shorting Jounce Therapeutics shares
There are currently 2.1 million Jounce Therapeutics shares held short by investors – that's known as Jounce Therapeutics's "short interest". This figure is 13.6% up from 1.8 million last month.
There are a few different ways that this level of interest in shorting Jounce Therapeutics shares can be evaluated.
Jounce Therapeutics's "short interest ratio" (SIR)
Jounce Therapeutics's "short interest ratio" (SIR) is the quantity of Jounce Therapeutics shares currently shorted divided by the average quantity of Jounce Therapeutics shares traded daily (recently around 757718.18181818). Jounce Therapeutics's SIR currently stands at 2.75. In other words for every 100,000 Jounce Therapeutics shares traded daily on the market, roughly 2750 shares are currently held short.
However Jounce Therapeutics's short interest can also be evaluated against the total number of Jounce Therapeutics shares, or, against the total number of tradable Jounce Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Jounce Therapeutics's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Jounce Therapeutics shares in existence, roughly 40 shares are currently held short) or 0.0686% of the tradable shares (for every 100,000 tradable Jounce Therapeutics shares, roughly 69 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Jounce Therapeutics.
Find out more about how you can short Jounce Therapeutics stock.
Jounce Therapeutics share dividends
We're not expecting Jounce Therapeutics to pay a dividend over the next 12 months.
Jounce Therapeutics share price volatility
Over the last 12 months, Jounce Therapeutics's shares have ranged in value from as little as $4.43 up to $14.84. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Jounce Therapeutics's is 1.1047. This would suggest that Jounce Therapeutics's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Jounce Therapeutics overview
Jounce Therapeutics, Inc. , a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid tumors. It is also developing JTX-4014, an anti-PD-1 antibody for combination therapy; JTX-8064, an antibody that binds to leukocyte immunoglobulin like receptor B2, which is a cell surface receptor expressed on macrophages; and JTX-1811, an anti-CCR8 monoclonal antibody designed to selectively deplete intra-tumoral T regulatory cells in the tumor microenvironment. Jounce Therapeutics, Inc. was incorporated in 2012 and is headquartered in Cambridge, Massachusetts. .
Stocks similar to Jounce Therapeutics
Jounce Therapeutics in the news
Partners HealthCare System, Inc Buys Pinduoduo Inc, DocuSign Inc, Snowflake Inc, Sells iShares Core S&P 500 ETF, iShares Core U.S. Aggregate Bond ETF, iShares MSCI ACWI Index Fund
Jounce Therapeutics: An Under The Radar And Undervalued Biotech
Jounce Therapeutics to Participate in William Blair’s Biotech Focus Conference
Frequently asked questionsWhat percentage of Jounce Therapeutics is owned by insiders or institutions?
Currently 18.271% of Jounce Therapeutics shares are held by insiders and 73.794% by institutions. How many people work for Jounce Therapeutics?
Latest data suggests 128 work at Jounce Therapeutics. When does the fiscal year end for Jounce Therapeutics?
Jounce Therapeutics's fiscal year ends in December. Where is Jounce Therapeutics based?
Jounce Therapeutics's address is: 780 Memorial Drive, Cambridge, MA, United States, 02139 What is Jounce Therapeutics's ISIN number?
Jounce Therapeutics's international securities identification number is: US4811161011 What is Jounce Therapeutics's CUSIP number?
Jounce Therapeutics's Committee on Uniform Securities Identification Procedures number is: 481116101
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert